View Bill Status
View Bill Text
View Statement of Purpose / Fiscal Impact
H0123.................................................by HEALTH AND WELFARE
CARISOPRODOL - Amends existing law to add carisoprodol to Schedule IV of
the Idaho controlled substance schedules.
02/07 House intro - 1st rdg - to printing
02/08 Rpt prt - to Health/Wel
03/03 Rpt out - ref'd to W/M
]]]] LEGISLATURE OF THE STATE OF IDAHO ]]]]
Fifty-eighth Legislature First Regular Session - 2005
IN THE HOUSE OF REPRESENTATIVES
HOUSE BILL NO. 123
BY HEALTH AND WELFARE COMMITTEE
1 AN ACT
2 RELATING TO CONTROLLED SUBSTANCES; AMENDING SECTION 37-2711, IDAHO CODE, TO
3 ADD CARISOPRODOL TO SCHEDULE IV OF IDAHO CONTROLLED SUBSTANCE SCHEDULES.
4 Be It Enacted by the Legislature of the State of Idaho:
5 SECTION 1. That Section 37-2711, Idaho Code, be, and the same is hereby
6 amended to read as follows:
7 37-2711. SCHEDULE IV. (a) Schedule IV shall consist of the drugs and
8 other substances, by whatever official name, common or usual name, chemical
9 name, or brand name designated, listed in this section.
10 (b) Narcotic drugs. Unless specifically excepted or unless listed in
11 another schedule, any material, compound, mixture, or preparation containing
12 any of the following narcotic drugs, or their salts calculated as the free
13 anhydrous base or alkaloid, in limited quantities as set forth below:
14 (1) No more than 1 milligram of difenoxin and not less than 25 micrograms
15 of atropine sulfate per dosage unit;
16 (2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,
17 2-diphenyl-3-methyl-2-propionoxybutane).
18 (c) Depressants. Unless specifically excepted or unless listed in another
19 schedule, any material, compound, mixture, or preparation which contains any
20 quantity of the following substances, including its salts, isomers, and salts
21 of isomers whenever the existence of such salts, isomers, and salts of isomers
22 is possible within the specific chemical designation:
23 (1) Alprazolam;
24 (2) Barbital;
25 (3) Bromazepam;
26 (4) Camazepam;
27 (5) Chloral betaine;
28 (6) Chloral hydrate;
29 (7) Chlordiazepoxide;
30 (8) Clobazam;
31 (9) Clonazepam;
32 (10) Clorazepate;
33 (11) Clotiazepam;
34 (12) Cloxazolam;
35 (13) Delorazepam;
36 (14) Diazepam;
37 (15) Estazolam;
38 (16) Ethchlorvynol;
39 (17) Ethinamate;
40 (18) Ethyl loflazepate;
41 (19) Fludiazepam;
42 (20) Flurazepam;
43 (21) Halazepam;
2
1 (22) Haloxazolam;
2 (23) Ketazolam;
3 (24) Loprazolam;
4 (25) Lorazepam;
5 (26) Lormetazepam;
6 (27) Mebutamate;
7 (28) Medazepam;
8 (29) Meprobamate;
9 (30) Methohexital;
10 (31) Methylphenobarbital (mephobarbital);
11 (32) Midazolam;
12 (33) Nimetazepam;
13 (34) Nitrazepam;
14 (35) Nordiazepam;
15 (36) Oxazepam;
16 (37) Oxazolam;
17 (38) Paraldehyde;
18 (39) Petrichloral;
19 (40) Phenobarbital;
20 (41) Pinazepam;
21 (42) Prazepam;
22 (43) Temazepam;
23 (44) Tetrazepam;
24 (45) Triazolam;
25 (46) Quazepam;
26 (47) Zolpidem.
27 (d) Fenfluramine - Any material, compound, mixture, or preparation which
28 contains any quantity of the following substances, including its salts,
29 isomers (whether optical, position, or geometric), and salts of such isomers,
30 whenever the existence of such salts, isomers, and salts of isomers is possi-
31 ble:
32 (1) Fenfluramine.
33 (e) Stimulants. Unless specifically excepted or unless listed in another
34 schedule, any material, compound, mixture, or preparation which contains any
35 quantity of the following substances having a stimulant effect on the central
36 nervous system, including its salts, isomers (whether optical, position, or
37 geometric), and salts of such isomers whenever the existence of such salts,
38 isomers, and salts of isomers is possible within the specific chemical desig-
39 nation:
40 (1) Cathine ((+)-norpseudoephedrine);
41 (2) Diethylpropion;
42 (3) Fencamfamin;
43 (4) Fenproporex;
44 (5) Mazindol;
45 (6) Mefenorex;
46 (7) Pemoline (including organometallic complexes and chelates thereof);
47 (8) Phentermine;
48 (9) Pipradrol;
49 (10) Sibutramine;
50 (11) SPA ((-)-1-dimethylamino-1,2-diphenylethane).
51 (f) Other substances. Unless specifically excepted, or unless listed in
52 another schedule, any material, compound, mixture or preparation which con-
53 tains any quantity of the following substance, including its salts:
54 (1) Carisoprodol;
55 (2) Pentazocine.
3
1 (g) The board may except by rule any compound, mixture, or preparation
2 containing any depressant substance listed in subsection (c) of this section
3 from the application of all or any part of this act if the compound, mixture,
4 or preparation contains one (1) or more active medicinal ingredients not hav-
5 ing a depressant effect on the central nervous system, and if the admixtures
6 are included therein in combinations, quantity, proportion, or concentration
7 that vitiate the potential for abuse of the substances which have a depressant
8 effect on the central nervous system.
STATEMENT OF PURPOSE
RS 14407
This bill is necessary to place the prescription drug Carisoprodol
(brand name Soma) into Schedule IV of the Idaho Controlled
Substance Schedules. The Idaho Board of Pharmacy continues to
encounter misuse of this particular prescription drug in a fashion
to indicate that it has a potential for abuse and that it may lead
to physical or psychological dependence. There is a currently
accepted medical use for this drug and placing this drug in
Schedule IV will allow that medical use to continue.
FISCAL NOTE
There will be no fiscal impact to the General Fund.
CONTACT
Name: R. K. "Mick" Markuson
Agency: Pharmacy, Board of
Phone: (208) 334-2356
Statement of Purpose/Fiscal Note H 123